1.
Int J Cardiol
; 131(2): 285-7, 2009 Jan 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17931721
RESUMO
A pilot study was performed to determine the effect of 40,000 IU Epo on myocardial damage in 51 patients with non-ST segment elevation acute coronary syndrome (non-STE ACS). No significant difference in myocardial damage was found, but an increased systolic blood pressure was noticed.